OGNOrganon & Co.
OGN
Organon & Co.1,609
Mkt Cap
$3.49BVolume
9.98M52W High
$13.3952W Low
$5.69PE Ratio
14.24OGN Fundamentals
Price
$13.29Prev Close
$13.25Open
$13.3150D MA
$7.82Beta
0.93Avg. Volume
17.84MEPS (Annual)
$0.7171P/B
4.60Rev/Employee
$621,600.00$10,095.68
Poll
Earnings Recap
• Reported GAAP EPS of $0.56 up 64.71% YoY • Reported revenue of $1.46B down -3.50% YoY
Bullish
Organon achieved increased net income and diluted EPS, driven by strong 23% biosimilars revenue growth and strategic expansion through European licensing rights for Emgality.
Bearish
Organon experienced declining total revenue and Women's Health segment sales, while the pending merger introduces significant uncertainties for completion, personnel retention, and customer relationships.